Showing results (71-80 of 320) with videos related to
Sort By:
Pageof 32
Journal of Cancer Research and Clinical Oncology|January 1, 1997
Nerve growth factor stimulates in vitro invasive capacity of DU145 human prostatic cancer cellsA A Geldof, M A De Kleijn, B R Rao, et al.British Journal of Urology|December 1, 1983
Low-dose doxorubicin in the management of advanced carcinoma of the prostateM R Robinson, S Chandrysekran, D W Newling, et al.The Journal of Urology|June 11, 2005
Local recurrence after cystectomy and survival of patients with bladder cancer: a population based study in greater amsterdamO Visser, J A Nieuwenhuijzen, S Horenblas, et al.The Journal of Urology|December 24, 1997
Primary skin closure of a large groin defect after inguinal lymphadenectomy for penile cancer using a skin stretching deviceP Melis, K E Bos, S HorenblasEuropean Urology|January 1, 1990
A multi-centre phase two study of intravesical epirubicin in the treatment of superficial bladder tumourJ A Cumming, D Kirk, D W Newling, et al.Addiction Biology|November 19, 2014
Postdependent state in rats as a model for medication development in alcoholismMarcus W Meinhardt, Wolfgang H SommerUrology|May 1, 1997
Radionuclide therapy for prostate cancer lumbar metastasis prolongs symptom-free survival in a rat modelA A Geldof, P L van den Tillaar, D W Newling, et al.European Urology|January 1, 1986
An evaluation of the immunochemical measurement of prostatic acid phosphatase and prostatic specific antigen in carcinoma of the prostateJ K Siddall, E H Cooper, D W Newling, et al.British Journal of Urology|December 1, 1985
Mitomycin C in superficial bladder cancer: 24-month follow-upJ J Somerville, D W Newling, B Richards, et al.British Journal of Urology|December 1, 1988
The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancerT G Armitage, E H Cooper, D W Newling, et al.Pageof 32